VMP 36130411000001107

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Oxycodone 20mg modified-release tablets
BNF code 0407020ADAAAGAG
Virtual Therapeutic Moiety Oxycodone
Date identifier became valid 5 Nov 2018
Previous product identifier 322695003
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Caution - AMP level prescribing advised
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Oxycodone hydrochloride
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 20.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tabletmodified-release.oral
Dose Form
Formulation Modified-release tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category Schedule 2 (CD)
Actual Medicinal Products
Ixyldone 20mg modified-release tablets (Morningside Healthcare Ltd)
Longtec 20mg modified-release tablets (CST Pharma Ltd)
Longtec 20mg modified-release tablets (Qdem Pharmaceuticals Ltd)
Oxeltra 20mg modified-release tablets (Wockhardt UK Ltd)
OxyContin 20mg modified-release tablets (Lexon (UK) Ltd)
OxyContin 20mg modified-release tablets (Napp Pharmaceuticals Ltd)
Oxylan 20mg prolonged-release tablets (G.L. Pharma UK Ltd)
Oxypro 20mg modified-release tablets (Ridge Pharma Ltd)
Reltebon 20mg modified-release tablets (Accord-UK Ltd)
Reltebon 20mg modified-release tablets (CST Pharma Ltd)
Virtual Medicinal Product Packs
Oxycodone 20mg modified-release tablets 28 tablet
Oxycodone 20mg modified-release tablets 56 tablet

dm+d data retrieved from TRUD: release NHSBSA_5.2.0_20240520000001, imported on 20th May 2024 at 05:03:18.

Feedback